The oncolytic effect of respiratory syncytial virus (RSV) in human skin cancer cell line, A431

Iranian Red Crescent Medical Journal

Volumn 15, Issue 1, 2012, Pages

  Salimi, Vahid ^a   Tavakoli Yaraki, Masoumeh ^b   Mahmoodi, Mahmood ^c   Shahabi, Shahram ^d   Gharagozlou, Mohammad Javad ^e   Shokri, Fazel ^a   Mokhtari Azad, Talat ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Apoptosis; Flow Cytometry; Oncolytic Viruses; Skin Neoplasms

Indexed keywords

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MICROSCOPY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SKIN CANCER; VIRUS CULTURE; VIRUS REPLICATION;

EID: 84872154330     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: 10.5812/ircmj.4722     Document Type: Article

References (30)

1. Hernandez-Alcoceba R. Recent advances in oncolytic virus design. Clin Transl Oncol. 2011;13(4):229-39.
2. Ottolino-Perry K, Diallo JS, Lichty BD, Bell JC, McCart JA. Intelligent design: combination therapy with oncolytic viruses. Mol Ther. 2010;18(2):251-63.
3. Hartkopf AD, Fehm T, Wallwiener D, Lauer UM. Oncolytic virotherapy of breast cancer. Gynecol Oncol. 2011;123(1):164-71.
4. Guse K, Cerullo V, Hemminki A. Oncolytic vaccinia virus for the treatment of cancer. Expert Opin Biol Ther. 2011;11(5):595-608.
5. Cripe TP, Wang PY, Marcato P, Mahller YY, Lee PW. Targeting cancer-initiating cells with oncolytic viruses. Mol Ther. 2009;17(10):1677-82.
6. Liu TC, Castelo-Branco P, Rabkin SD, Martuza RL. Trichostatin A and oncolytic HSV combination therapy shows enhanced antitumoral and antiangiogenic effects. Mol Ther. 2008;16(6):1041-7.
7. Galanis E. Therapeutic potential of oncolytic measles virus: promises and challenges. Clin Pharmacol Ther. 2010;88(5):620-5.
8. Allen C, Paraskevakou G, Liu C, Iankov ID, Msaouel P, Zollman P, et al. Oncolytic measles virus strains in the treatment of gliomas. Expert Opin Biol Ther. 2008;8(2):213-20.
9. Reid EG. Bortezomib-induced Epstein-Barr virus and Kaposi sarcoma herpesvirus lytic gene expression: oncolytic strategies. Curr Opin Oncol. 2011;23(5):482-7.
10. Kominsky DJ, Bickel RJ, Tyler KL. Reovirus-induced apoptosis requires both death receptor- and mitochondrial-mediated caspase-dependent pathways of cell death. Cell Death Differ. 2002;9(9):926-33.
11. Meng S, Zhou Z, Chen F, Kong X, Liu H, Jiang K, et al. Newcastle disease virus induces apoptosis in cisplatin-resistant human lung adenocarcinoma A549 cells in vitro and in vivo. Cancer Lett. 2012;317(1):56-64.
12. Lomonosova E, Subramanian T, Chinnadurai G. Requirement of BAX for efficient adenovirus-induced apoptosis. J Virol. 2002;76(22):11283-90.
13. Price GE, Smith H, Sweet C. Differential induction of cytotoxicity and apoptosis by influenza virus strains of differing virulence. J Gen Virol. 1997;78 (Pt 11):2821-9.
14. Balachandran S, Porosnicu M, Barber GN. Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or myc function and involves the induction of apoptosis. J Virol. 2001;75(7):3474-9.
15. Colston JT, Chandrasekar B, Freeman GL. Expression of apoptosis-related proteins in experimental coxsackievirus myocarditis. Cardiovasc Res. 1998;38(1):158-68.
16. Chang J. Current progress on development of respiratory syncytial virus vaccine. BMB Rep. 2011;44(4):232-7.
17. Wu P, Dupont WD, Griffin MR, Carroll KN, Mitchel EF, Gebretsadik T, et al. Evidence of a causal role of winter virus infection during infancy in early childhood asthma. Am J Respir Crit Care Med. 2008;178(11):1123-9.
18. Walsh EE. Respiratory syncytial virus infection in adults. Semin Respir Crit Care Med. 2011;32(4):423-32.
19. Bitko V, Barik S. An endoplasmic reticulum-specific stress-activated caspase (caspase-12) is implicated in the apoptosis of A549 epithelial cells by respiratory syncytial virus. J Cell Biochem. 2001;80(3):441-54.
20. Echchgadda I, Kota S, DeLa Cruz I, Sabbah A, Chang T, Harnack R, et al. Anticancer oncolytic activity of respiratory syncytial virus. Cancer Gene Ther. 2009;16(12):923-35.
21. O'Donnell D R, Milligan L, Stark JM. Induction of CD95 (Fas) and apoptosis in respiratory epithelial cell cultures following respiratory syncytial virus infection. Virology. 1999;257(1):198-207.
22. Wang SZ, Smith PK, Lovejoy M, Bowden JJ, Alpers JH, Forsyth KD. The apoptosis of neutrophils is accelerated in respiratory syncytial virus (RSV)-induced bronchiolitis. Clin Exp Immunol. 1998;114(1):49-54.
23. Thomas KW, Monick MM, Staber JM, Yarovinsky T, Carter AB, Hunninghake GW. Respiratory syncytial virus inhibits apoptosis and induces NF-kappa B activity through a phosphatidylinositol 3-kinase-dependent pathway. J Biol Chem. 2002;277(1):492-501.
24. Aamdal S. Current approaches to adjuvant therapy of melanoma. Eur J Cancer. 2011;47 Suppl 3:S336-7.
25. Kotelkin A, Prikhod'ko EA, Cohen JI, Collins PL, Bukreyev A. Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J Virol. 2003;77(17):9156-72.
26. Kasibhatla S, Tseng B. Why target apoptosis in cancer treatment? Mol Cancer Ther. 2003;2(6):573-80.
27. Echchgadda I, Chang TH, Sabbah A, Bakri I, Ikeno Y, Hubbard GB, et al. Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense. BMC Cancer. 2011;11:43.
28. Svajdler M, Rychly B, Benicky M. [Targeted therapy of melanoma: fact or fiction?]. Cesk Patol. 2011;47(4):165-7.
29. Eckardt-Michel J, Lorek M, Baxmann D, Grunwald T, Keil GM, Zimmer G. The fusion protein of respiratory syncytial virus triggers p53-dependent apoptosis. J Virol. 2008;82(7):3236-49.
30. Lindemans CA, Coffer PJ, Schellens IM, de Graaff PM, Kimpen JL, Koenderman L. Respiratory syncytial virus inhibits granulocyte apoptosis through a phosphatidylinositol 3-kinase and NF-kappaB-dependent mechanism. J Immunol. 2006;176(9):5529-37.